Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 2

Sponsor Class

OTHER 6INDUSTRY 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Myeloid 2Dermatologic 2Other hematologic neoplasm 1Lymphoid 1

Conditions

Neoplasms 3214Carcinoma, Non-Small-Cell Lung 2727Breast Neoplasms 2550Colorectal Neoplasms 1461Prostatic Neoplasms 1307Neoplasm Metastasis 1300Multiple Myeloma 1112Melanoma 1103Ovarian Neoplasms 1006Lung Neoplasms 944Recurrence 924Leukemia, Myeloid, Acute 879Pancreatic Neoplasms 832Lymphoma, Non-Hodgkin 767Lymphoma 713Stomach Neoplasms 692Carcinoma, Renal Cell 660Carcinoma, Hepatocellular 647Leukemia, Lymphocytic, Chronic, B-Cell 560Squamous Cell Carcinoma of Head and Neck 550Lymphoma, Follicular 515Head and Neck Neoplasms 490Glioblastoma 472Small Cell Lung Carcinoma 447Lymphoma, Large B-Cell, Diffuse 440Triple Negative Breast Neoplasms 435Advanced Solid Tumors 432Leukemia 426Uterine Cervical Neoplasms 420Urinary Bladder Neoplasms 405

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
INDUSTRY × Mastocytosis, Cutaneous × Clear all
NCT02620254 2021-02-04

Mast Cell Connect: A Registry for Patients With Mastocytosis

Blueprint Medicines Corporation

Completed
743 enrolled
DermatologicLymphoidMyeloidOther hematologic neoplasm

Telangiectasia macularis eruptiva perstans, Leukemia, Mast-Cell, Mastocytosis, Urticaria Pigmentosa, Mastocytosis, Cutaneous, Mastocytosis, Systemic

NCT00457288 2007-11-12

Efficacy and Safety of TF002 in Cutaneous Mastocytosis

JADO Technologies GmbH

Phase 2 Completed
30 enrolled
DermatologicMyeloid

Mastocytosis, Cutaneous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡